Correlation Between SCI Pharmtech and Jourdeness

Can any of the company-specific risk be diversified away by investing in both SCI Pharmtech and Jourdeness at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining SCI Pharmtech and Jourdeness into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SCI Pharmtech and Jourdeness Group, you can compare the effects of market volatilities on SCI Pharmtech and Jourdeness and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in SCI Pharmtech with a short position of Jourdeness. Check out your portfolio center. Please also check ongoing floating volatility patterns of SCI Pharmtech and Jourdeness.

Diversification Opportunities for SCI Pharmtech and Jourdeness

-0.21

Correlation Coefficient

SCI Pharmtech  Jourdeness

Very good diversification

The 3 months correlation between SCI and Jourdeness is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding SCI Pharmtech and Jourdeness Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Jourdeness Group and SCI Pharmtech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SCI Pharmtech are associated (or correlated) with Jourdeness. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Jourdeness Group has no effect on the direction of SCI Pharmtech i.e., SCI Pharmtech and Jourdeness go up and down completely randomly.

Pair Corralation between SCI Pharmtech and Jourdeness

Assuming the 90 days trading horizon SCI Pharmtech is expected to generate 0.43 times more return on investment than Jourdeness. However, SCI Pharmtech is 2.33 times less risky than Jourdeness. It trades about 0.05 of its potential returns per unit of risk. Jourdeness Group is currently generating about 0.01 per unit of risk. If you would invest  8,780  in SCI Pharmtech on September 16, 2024 and sell it today you would earn a total of  280.00  from holding SCI Pharmtech or generate 3.19% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

SCI Pharmtech  vs.  Jourdeness Group

SCI Pharmtech

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in SCI Pharmtech are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, SCI Pharmtech is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Jourdeness Group

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Jourdeness Group has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Jourdeness is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with SCI Pharmtech and Jourdeness

The main advantage of trading using opposite SCI Pharmtech and Jourdeness positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if SCI Pharmtech position performs unexpectedly, Jourdeness can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Jourdeness will offset losses from the drop in Jourdeness' long position.

The idea behind SCI Pharmtech and Jourdeness Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.